Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 29 - Non-central analgesic, antipyretic or antiinflammatory agents, e.g antirheumatic agents; Non-steroidal antiinflammatory drugs (nsaids)
Patents for A61P 29 - Non-central analgesic, antipyretic or antiinflammatory agents, e.g antirheumatic agents; Non-steroidal antiinflammatory drugs (nsaids) (127,169)
09/2003
09/11/2003US20030170839 Type 2 cytokine receptor and nucleic acids encoding same
09/11/2003US20030170785 CDNA encoding the human alpha2 delta4 calcium channel subunit
09/11/2003US20030170746 Method for screening an agent for ability to inhibit heparanase activity
09/11/2003US20030170648 Autoimmune diseases; inflammatory bowel disease; multiple sclerosis; rheumatic diseases; modulate gene expression
09/11/2003US20030170381 Piezoelectric element and process for production thereof
09/11/2003US20030170331 Plant extract of the olea europaea as no-synthase inhibitor and uses
09/11/2003US20030170329 Cytokine production inhibitors, agents for protecting and promoting liver funtion, anti-inflammatory agents, immunosuppressants, drugs, cosmetics, foods and food materials
09/11/2003US20030170320 Extract is composed of carboxy alkyl esters, especially quinic acid lactone.
09/11/2003US20030170319 Nutrient pharmaceutical formulation comprising polyphenols and use in treatment of cancer
09/11/2003US20030170315 Bioactivation of iron salt, especially an ferric ferrous salt, by adding a magnesium salt (MgCl2); useful as a medicine to treat diseases such as diabetes, freshness preservative agent, and animal and plant growth promoter
09/11/2003US20030170312 Method for coating solid particles with a thermofusible agent, and resulting coated solid particles
09/11/2003US20030170303 That has low water solubility such as celecoxib; and a release- extending polymer.
09/11/2003US20030170297 Lipid-based drug delivery systems containing phospholipase a2 degradable lipid derivatives for topical application to the skin
09/11/2003US20030170275 Such as pain, mental disorders such as schizophrenia and stress-related disorders such as depression using, especially, M. vaccae material.
09/11/2003US20030170233 Treating Autoimmune Diseases with Humanized Anti-CD40L Antibody
09/11/2003US20030170217 Bifidobacterium in the treatment of inflammatory disease
09/11/2003US20030170212 Ex-vivo priming for generating cytotoxic T lymphocytes specific for non-tumor antigens to treat autoimmune and allergic disease
09/11/2003US20030170174 For therapy of diseases, such as parasitic and viral infections, conditions associated with inflammation and infection, and conditions mediated by cell-proliferation or collagen formation; contrast agents
09/10/2003EP1343013A1 Methods of screening apoptosis modulating compounds, compounds identified by said methods and use of said compounds as therapeutic agents.
09/10/2003EP1342721A1 Sulfonamides and derivatives thereof that modulate the activity of endothelin
09/10/2003EP1342472A1 Analgesic and anti-inflammatory patches for external use containing 4-biphenylylylacetic acid
09/10/2003EP1341920A2 Human elongase genes and uses thereof
09/10/2003EP1341918A2 Isolated human kinase proteins, nucleic acid molecules encoding human kinase proteins, and uses thereof
09/10/2003EP1341914A2 Regulation of angiogenesis with zinc finger proteins
09/10/2003EP1341905A2 Tec kinase assay
09/10/2003EP1341819A2 Peptides and/or proteins and use thereof for the production of a therapeutic and/or prophylactic medicament
09/10/2003EP1341811A2 Orally ingestible preparation of mistletoe lectins and method
09/10/2003EP1341795A2 Novel labeled resiniferatoxin derivatives
09/10/2003EP1341792A2 Amido ether substituted imidazoquinolines
09/10/2003EP1341791A2 Thioether substituted imidazoquinolines
09/10/2003EP1341790A2 Sulfonamido ether substituted imidazoquinolines
09/10/2003EP1341789A2 Aryl ether substituted imidazoquinolines
09/10/2003EP1341786A1 Substituted derivatives of aminofuran-2-yl-acetic acid and aminothien-2-yl-acetic acid and the use thereof for treating migraines and pain
09/10/2003EP1341782A2 Inhibitors of p38 kinase
09/10/2003EP1341768A1 Therapeutic benzimidazole compounds
09/10/2003EP1341767A2 Imidazole and benzimidazole caspase inhibitors and uses thereof
09/10/2003EP1341765A1 Therapeutic compounds
09/10/2003EP1341761A1 SUBSTITUTED INDOLES, PHARMACEUTICAL COMPOSITIONS CONTAINING SUCH INDOLES AND THEIR USE AS PPAR-$g(g) BINDING AGENTS
09/10/2003EP1341755A1 Carboxylic acid amide derivatives and their use in the treatment of thromboembolic diseases and tumours
09/10/2003EP1341552A2 Treatment of immune-mediated diseases by oral administration of plasma fractions
09/10/2003EP1341546A2 Kyberdrug as autovaccines with immune-regulating effects
09/10/2003EP1341542A2 Organic compounds
09/10/2003EP1341540A2 Tyrosine kinase inhibitors
09/10/2003EP1341539A1 Anti-inflammatory agents
09/10/2003EP1341537A2 Pharmaceutically active isoindoline derivatives
09/10/2003EP1341521A2 Nanoparticulate compositions comprising a drug and copolymers of vinyl pyrrolidone and vinyl acetate as surface stabilizers
09/10/2003EP1341497A2 Receptor antagonist-lipid conjugates and delivery vehicles containing same
09/10/2003EP1194401B1 Diacylhydrazine derivatives
09/10/2003EP1181030B1 Tanacetum parthenium extract
09/10/2003EP1140818B1 Amidomalonamides and their use as inhibitors of matrix metalloproteinase
09/10/2003EP1090023B1 2-(purin-9-yl)-tetrahydrofuran-3,4-diol derivatives
09/10/2003EP1090021B1 2-(purin-9-yl)-tetrahydrofuran-3,4-diol derivatives
09/10/2003EP0991650B1 Novel n-benzenesulphonyl-l-proline compounds, preparation method and use in therapy
09/10/2003EP0973501B1 Aqueous suspension for nasal administration of loteprednol
09/10/2003EP0934264B1 Pyrrolidinyl and pyrrolinyl ethylamine compounds as kappa agonists
09/10/2003EP0912518B1 Substituted pyridines as selective cyclooxygenase-2 inhibitors
09/10/2003EP0906122B1 Activated linkers and methods for making and purifying the same
09/10/2003EP0772396B1 Method of regulating immune function
09/10/2003EP0594732B1 Humanized antibody against cd18
09/10/2003CN1441843A Extracellular matrix protein
09/10/2003CN1441808A Chemokine receptor modulators, production and use
09/10/2003CN1441803A Indoloquinazolinones
09/10/2003CN1441796A Cyclic substituted aminomethyl compounds and medicaments containing said compounds
09/10/2003CN1441788A Novel arylethene-sulfonamides compounds
09/10/2003CN1441787A Modulators of TNF-alpha signaling
09/10/2003CN1441782A N-oxides as NK1 receptor antagonist prodrugs of 4-phenyl-pyridine derivatives
09/10/2003CN1441781A Pharmaceutically active piperidine derivatives, in particular as modulators of chemokine receptor activity
09/10/2003CN1441780A Piperidine compounds for use as CCR-3 inhibitors
09/10/2003CN1441777A Inhibiting angiogenesis and tumor growth
09/10/2003CN1441776A Novel aryl, alkenyl and alkynl 4-dedimethylamino tetracycline derivatives
09/10/2003CN1441773A Cyclohexylamine derivative as subtype selective NMDA receptor Antagonists
09/10/2003CN1441770A Modified forms of pharmacologically active agents and uses therefor
09/10/2003CN1441675A Compositions and methods for achieving immune suppression
09/10/2003CN1441667A Pharmaceutical compositions
09/10/2003CN1440971A Vitronectin receptor antagnist, its preparation and use
09/10/2003CN1440816A Improvement for diagnosis and/or therapeutic agnet and its relative improvement
09/10/2003CN1440799A Women's medicine and its prepn
09/10/2003CN1440797A Medicine for stopping pain and strengthening bone
09/10/2003CN1440787A Medicine for treating rheumatic and rheumatoid diseases
09/10/2003CN1440773A Prepn process of Qingkailing injection and injection powder and its quality control method
09/10/2003CN1440768A Chinese medicine for treating rheumatic diseases and its prepn
09/10/2003CN1440760A Dilingquan powder producing process
09/10/2003CN1440756A Medicine for treating high fever and diseases caused by high fever and its prepn process
09/10/2003CN1120838C Dihydrobenzofuran compounds useful as anti-inflammatong agents
09/09/2003US6617426 Peptide analogs of given formula; useful in treating neurodegenerative, autoimmune, cognitive disorders, stroke and traumatic injury
09/09/2003US6617352 Compounds and methods for the inhibition of the expression of VCAM-1
09/09/2003US6617345 Cyclooxygenase-2 inhibitor is (5-bromo-2-(4-fluorophenyl )-3-(4-(methylsulfonyl)phey)-thiophene), N-(2-(cyclohexyloxy 4-nitrophenyl)-methanesulfonamide), meloxicam, flosulide or cyclic substituted phenyl sulfones or sulfonamides
09/09/2003US6617324 Substituted pyrazoles as p38 kinase inhibitors
09/09/2003US6617317 Boronic ester and acid compositions
09/09/2003US6616943 Composition comprising Wenguanguo extracts and methods for preparing same
09/09/2003CA2263566C Substituted 6,5-hetero-bicyclic derivatives
09/09/2003CA2078814C Substituted pyridinylamino-1h-indoles, 1h-indazoles, 2h-indazoles, benzo[b]thiophenes and 1,2-benzisothiazoles, a process for their preparation and their use as medicaments
09/04/2003WO2003073107A2 Neuropeptide receptor and uses thereof
09/04/2003WO2003073099A1 Method for diagnosing and monitoring hemostatic dysfunction, severe infection and systematic inflammatory response syndrome
09/04/2003WO2003072789A2 Microorganisms as carriers of nucleotide sequences coding for cell antigens used for the treatment of tumors
09/04/2003WO2003072704A2 RNA INTERFERENCE MEDIATED INHIBITION OF PLATELET DERIVED GROWTH FACTOR (PDGF) AND PLATELET DERIVED GROWTH FACTOR RECEPTOR (PDGFR) GENE EXPRESSION USING SHORT INTERFERING NUCLEIC ACID (siNA)
09/04/2003WO2003072606A2 Galectin-8and functional derivatives as binding agents for cd44 glycoproteins and methods of use
09/04/2003WO2003072569A1 1,4-disubstituted benzofused cycloalkyl urea compounds useful in treating cytokine mediated diseases
09/04/2003WO2003072558A2 Arylsulfone derivatives
09/04/2003WO2003072557A1 5-phenylthiazole derivatives and use as pi3 kinase inhibitors
1 ... 812 813 814 815 816 817 818 819 820 821 822 823 824 825 826 827 828 829 830 831 832 ... 1272